Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Federico J. Mensa
Glecaprevir/Pibrentasvir for 8 Weeks in Treatment-Naïve Patients With Chronic HCV Genotypes 1–6 and Compensated Cirrhosis: The EXPEDITION-8 Trial
Journal of Hepatology
Hepatology
Related publications
Effectiveness of 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve, Compensated Cirrhotic Patients With Chronic Hepatitis C Infection
Advances in Therapy
Medicine
Pharmacology
Glecaprevir/Pibrentasvir for the Treatment of Chronic Hepatitis C: Design, Development, and Place in Therapy
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Ombitasvir/Paritaprevir/Ritonavir Plus Ribavirin for 24 Weeks in Patients With HCV GT4 and Compensated Cirrhosis (AGATE-I Part II)
Health Science Reports
Real World Effectiveness of Ledipasvir/Sofosbuvir (LDV/SOF) for 8 Weeks in Patients Coinfected With HCV and HIV-1
Journal of Hepatology
Hepatology
Elbasvir/Grazoprevir and Sofosbuvir for HCV Genotype 3 Infection With Compensated Cirrhosis: A Randomized Trial
Hepatology
Medicine
Hepatology
Effectiveness of 8- Or 12-Weeks of Ledipasvir and Sofosbuvir in Real-World Treatment-Naïve, Genotype 1 Hepatitis C Infected Patients
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy
Gastroenterology
Hepatology
Gastroenterology
Glecaprevir and Pibrentasvir Combination Therapy for Hepatitis C Virus-Infected Japanese Patients on Hemodialysis
Renal Replacement Therapy
Evaluation of Some Non Invasive Predictors for Presence of Esophageal Varices in Patients With Compensated HCV Positive Cirrhosis
International Journal of Science and Research (IJSR)
